Bibliography of
our source material
Here you will find our general frequently asked questions.
If your question is not answered here, please feel free to
contact us.
Return to the FAQs index
1. Vitiligo bibliography
and references
2. Psoriasis
bibliography and references
3. Acne bibliography
and references
1. Vitiligo bibliography and references
AHMED, S. (1998) ‘Animated Borders: Skin, Colour and
Tanning', in Shildrick, M. and Price, J. (eds.) Vital Signs,
Texts, Borders and Biomedicine , Edinburgh : Edinburgh
University Press.
BBC RADIO 4 (2002) ‘Skin Deep' 13 October 2002 ,
13.30-14.00pm .
BRYMAN, A. (2001) Social Research Methods , Oxford : Oxford
University Press.
BULL, R. and DAVID, I. (1986) ‘The Stigmatising Effect of
Facial Disfigurement', Journal of Cross-Cultural Psychology
, vol. 17, no. 1, pp. 99-108.
ELLIS, C. (1998) ‘ “I Hate My Voice”: Coming to Terms with
Minor Bodily Stigmas', The Sociological Quarterly , vol. 39,
no. 4, pp. 517-537.
FINALY, A. Y. and COLES, E. C. (1995) ‘The Effect of Severe
Psoriasis on the Quality of Life of 369 Patients', British
Journal of Dermatology , vol. 132, pp. 236-244.
GARDENER, C. B. (1991) ‘Stigma and the Public Self: Notes on
Communication, Self and Others', Journal of Contemporary
Ethnography , vol. 20, no. 3, pp. 251-262.
GOFFMAN, E. (1963) Stigma: Notes on the Management of
Spoiled Identity , London : Prentice-Hall Press.
GUARDIAN (1997) ‘Losing Face: Janet Haslam on the Skin
Disease which Causes Gradual Loss of Colour' 2 December 1997
, p. 16.
HAWKESWORTH, M. (2001) ‘Disabling Spatialities and the
Regulation of a Visible Secret', Urban Studies , vol. 38,
no. 2, pp. 299-318.
JACOBY, A. (1998) ‘Felt Versus Enacted Stigma: A Concept
Revisited', Social Science and Medicine , vol. 38, no. 2,
pp. 269-274.
KENT , G. (1999) ‘Correlates of Perceived Stigma in
Vitiligo', Psychology and Health , vol. 15, pp. 241-251.
KENT, G. (2000) ‘Understanding the Experiences of People
with Disfigurement: An Integration of Four Models of Social
and Psychological Functioning', Psychology, Health and
Medicine , vol. 5, no. 2, pp. 117-129
LEE-TREWEEK, G. and LINKGOLE, S. (eds.) (2000) Danger in the
Field: Risk and Ethics in Social Research , London :
Routledge.
LESAGE, M. (2002) Vitiligo: Understanding the Loss of Skin
Colour , second edition, London : The Vitiligo Society.
MAGIONE, T. W. (1995) Mail Surveys: Improving the Quality ,
Thousand Oaks , California : Sage Publications.
MONTAGU, A. (1971) Touching: The Human Significance of the
Skin , London : Columbia University Press.
NEW YORK TIMES (2003) ‘A Guide to Skin Disease Through the
Eyes of a Boy' 15 July 2003 , p. F7, col. 5.
OBSERVER (2002) ‘Ebony and Ivory' 10 November 2002 , p. 23.
PORTER, J. R. and BEUF, A. H. (1988) ‘Response of Older
People to Impaired Appearance: The Effect of Age on
Disturbance of Vitiligo', Journal of Ageing Studies , vol.
2, no. 2, pp. 167-181.
PORTER, J. R. et. al. (1990) ‘The Effect of Vitiligo on
Sexual Relationships', Journal of the American Academy of
Dermatology , vol. 22, pp. 221-222.
PORTER, J. R. and BEUF, A. H. (1991) ‘Racial Variation in
Reaction to Physical Stigma: A Study of Degree of
Disturbance by Vitiligo Among Black and White Patients',
Journal of Health and Social Behaviour , vol. 32, no. 2, pp.
192-204.
ROSENBERG , M. (1965) Society and the Adolescent Self-Image
, Princeton , New Jersey : Princeton University Press.
SCAMBLER, G. AND HOPKINS, A. (1980) ‘Being Epileptic: Coming
to Terms with Stigma', Sociology of Health and Illness ,
vol. 8, pp. 26-45.
WILLIAMS, J. I. (1971) ‘Disease as Deviance', Social Science
and Medicine , vol. 5, pp. 219-226.
[top of page]
2. Psoriasis bibliography and references
Bowcock AM: Genetic locus for psoriasis identified. Ann
Med 1995 Apr; 27(2): 183-6[Medline].
Cullar ML, Espinoza LR: Psoriatic arthritis: Current
developments. J Fla Med Assoc 1995; 82 (5): 338-42.
Elder JT, Henseler T, Christophers E, et al: Of genes and
antigens: the inheritance of psoriasis. J Invest Dermatol
1994 Nov; 103(5 Suppl): 150S-153S[Medline].
Farber EM, Nall L: Psoriasis. A review of recent advances in
treatment. Drugs 1984 Oct; 28(4): 324-46[Medline].
Farber EM: Therapeutic perspectives in psoriasis. Int J
Dermatol 1995 Jul; 34(7): 456-60[Medline].
Greaves MW, Weinstein GD: Treatment of psoriasis. N Engl J
Med 1995 Mar 2; 332(9): 581-8[Medline].
Lebwohl MG: The evolution of vitamin D analogues for the
treatment of psoriasis. Arch Dermatol 1995 Nov; 131(11):
1323-4[Medline].
Lewis HM: Therapeutic progress. II: Treatment of psoriasis.
J Clin Pharm Ther 1994 Aug; 19(4): 223-32[Medline].
Naldi L: Psoriasis. Dermatol Clin 1995 Jul; 13(3):
635-47[Medline].
Pines A, Ehrenfeld M, Fisman EZ, et al: Mitral valve
prolapse in psoriatic arthritis. Arch Intern Med 1986 Jul;
146(7): 1371-3[Medline].
Raychaudhuri SP, Rein G, Farber EM: Neuropathogenesis and
neuropharmacology of psoriasis. Int J Dermatol 1995 Oct;
34(10): 685-93[Medline].
Task Force on Psoriasis: Guidelines of care for psoriasis.
Committee on Guidelines of Care. Task Force on Psoriasis. J
Am Acad Dermatol 1993 Apr; 28(4): 632-7[Medline].
Valdimarsson H, Sigmundsdottir H, Jonsdottir I: Is psoriasis
induced by streptococcal superantigens and maintained by M-
protein-specific T cells that cross-react with keratin? Clin
Exp Immunol 1997 Jan; 107 Suppl 1: 21-4[Medline].
Weinstein, GD: Tazarotene: A novel retinoid for the topical
treatment of psoriasis. Pharmacy and Therapeutics 1997;
August: 377-81.
Charmaz K. Good Days, Bad Days: The Self in Chronic
Illness and Time. New Brunswick, NJ: Rutgers University
Press; 1993.
Cram DL. Coping With Psoriasis: A Patient's Guide to
Treatment. Omaha, Neb: Addicus Books; 2000.
Derzaph ED. Psoriasis: The Struggle and the Triumph—A
Healthy Transformation for Everyone Living With Psoriasis.
Bloomington, Ind: 1stBooks Library; 2003.
Dewke ES. Flake: Confessions of a Psoriatic. Lexington,
Ky: BGC Books; 1996.
Grossbart TA, Sherman C. Skin Deep: A Mind/Body Program
for Healthy Skin. Rev ed. Santa Fe, NM: Health Press; 1992.
LeVan L. The Psoriasis Cure. Garden City Park, NY: Avery
Publishing Group; 1999.
Lowe NJ. Managing Your Psoriasis. New York, NY:
Mastermedia; 1993.
National Psoriasis Foundation. The Best of It Works For
Me: 1991–1999. Portland, Ore: National Psoriasis Foundation;
2000.
Pitzele SK. We Are Not Alone: Learning to Live With
Chronic Illness. New York, NY: Workman Publishing; 1986.
Abell E. Treatment of psoriatic nail dystrophy. Br J
Dermatol 1972;86:79-82.
duVivier A, Stoughton RB. Tachyphylaxis to the action of
topically applied corticosteroids. Arch Dermatol
1975;111:581-3.
Katz HI, Hien HT, Prawer SE, et al. Superpotent topical
steroid treatment of psoriasis vulgaris: clinical efficacy
and adrenal function. J AM ACAD DERMATOL 1987;16:804-11.
Lee SS. Topical steroids (review). Int J Dermatol
1981;20:632-41.
Nilsson JE, Gip LJ. Systemic effects of local treatment
with high doses of potent corticosteroids in psoriatics.
Acta Derm Venereol (Stockh) 1979;59:245-8.
Tan PL, Barnett GL, Flowers FP, et al. Current topical
corticosteroid preparations. J AM ACAD DERMATOL
1986;14:79-93.
Vickers CFH. Topical corticosteroids. In: Fitzpatrick TB,
Eisen AZ, Wolff K, et al, eds. Dermatology in general
medicine. 3rd ed. New York: McGraw-Hill, 1987:2540-5.
Chapman RS, Finn OA. An assessment of high and low
temperature tars in psoriasis. Br J Dermatol 1976;94:71-4.
Finlay AY, Young DW. Short contact coal tar therapy for
psoriasis. Clin Exp Dermatol 1985;10:371-4.
Lavker RM, Grove GL, Kligman AM. The atrophogenic effect
of crude coal tar on human epidermis. Br J Dermatol
1981;105:77-82.
Lin AN, Moses K. Tar revisited. Int J Dermatol
1985;24:216-8.
Lowe NJ, Wortzman MS, Breeding J, et al. Coal tar
phototherapy for psoriasis reevaluated: erythemogenic versus
suberythemogenic ultraviolet with a tar extract in oil and
crude coal tar. J AM ACAD DERMATOL 1983;8:781-9.
Petrozzi JW, Barton JO, Kaidbey KH, et al. Updating the
Goeckerman regimen for psoriasis. Br J Dermatol
1978;98:437-44.
Stern RS, Gange RW, Parrish JA, et al. Contribution of
topical tar oil to ultraviolet B phototherapy for psoriasis.
J AM ACAD DERMATOL 1986;14:742-7.
Young E. The external treatment of psoriasis: a controlled
investigation of the effects of coal tar. Br J Dermatol
1970;82:510-5.
Abel EA, O’Connell BM, Farber EM. Psoriasis day care
center at Stanford: part-time and full-time programs. Int J
Dermatol 1987;26:500-7.
Ashton RE, Andre P, Lowe NJ, et al. Anthralin: historical
and current perspectives. J AM ACAD DERMATOL 1983;9:173-92.
Ingram JT. The approach to psoriasis. Br Med J 1953;591-4.
Lowe NJ, Ashton RE, Koudsi H, et al. Anthralin for
psoriasis: short-contact anthralin therapy compared with
topical steroid and conventional anthralin. J AM ACAD
DERMATOL 1984;10:69-72.
Ryatt KS, Statham BN, Rowell NR. Short-contact
modification of the Ingram regimen. Br J Dermatol
1984;111:455-9.
Davies MG, Briffa DV, Greeves MW. Systemic toxicity from
topically applied salicylic acid. Br Med J 1979;1:661.
Going SM, Guyer BM, Jarvie DR, et al. Salicylic acid gel
for scalp psoriasis. Clin Exp Dermatol 1986;11:260-2.
Goldsmith LA. Salicylic acid. Int J Dermatol 1979;18:32-6.
Hulsebosch HJ, Ponec-Waelsch M. The interaction of
anthralin, salicylic acid and zinc oxide in pastes.
Dermatologica 1972;144:287-93.
Van Scott EJ, Yu RJ. Alpha hydroxy acids: procedures for
use in clinical practice. Cutis 1989;43:222-8.
Van Scott EJ, Yu RJ. Control of keratinization with
L-hydroxy acids and related compounds. Arch Dermatol
1974;110:586-90.
Rosenberg EW, Noah PW, Zanolli MD, et al. Use of rifampin
with penicillin and erythromycin in the treatment of
psoriasis. J AM ACAD DERMATOL 1986;14:701-4.
Rosenberg EW, Skinner RB, Noah PW. Antimicrobial treatment
of psoriasis. In: Roenigk HH, Maibach HI, eds. Psoriasis.
2nd ed. revised and expanded. New York: Marcel Dekker,
1991:815-22.
Tefler NR, Chalmers RJG, Wale K, et al. The role of
streptococcal infection in the initiation of guttate
psoriasis. Arch Dermatol 1992;128:39-42.
Whyte HS, Baughman RD. Acute guttate psoriasis and
streptococcal infection. Arch Dermatol 1964;89:350-6.
Ashton RE, Millward-Sadler GH, White JE. Complications in
methotrexate treatment of psoriasis with particular
reference to liver fibrosis. J Invest Dermatol
1982;79-229-32.
Dahl MGC. Methotrexate and the liver. Br J Dermatol
1969;81:465-7.
Hanno R, Gruber GG, Owen LG, et al. Methotrexate in
psoriasis. J AM ACAD DERMATOL 1980;2:171-4.
Jolivet J, Cowan KH, Curg GA, et al. The pharmacology and
clinical use of methotrexate. N Engl J Med
1983;309:1094-104.
Reese LT, Grisham JW, Aach RD, et al. Effects of
methotrexate on the liver in psoriasis. J Invest Dermatol
1974;62:597-602.
Roenigk HH, Auerbach R, Maibach HI, et al. Methotrexate in
psoriasis: revised guidelines. J AM ACAD DERMATOL
1988;19:145-56.
Weinstein GD. Methotrexate. Ann Intern Med
1977;86:199-204.
Zachariae H, Kragballe K, Søgaard H. Methotrexate-induced
liver cirrhosis. Br J Dermatol 1980;102:407-12.
Leavell UW, Mersack IP, Smith C. Survey of the treatment
of psoriasis with hydroxyurea. Arch Dermatol 1973;107:467.
McDonald CJ. Chemotherapy of psoriasis. Int J Dermatol
1975;14:563-74.
Moschella SL. Chemotherapy of psoriasis: ten years of
experience.. Int J Dermatol 1976;15:373-8.
Moschella SL, Greenwald MA. Psoriasis with hydroxyurea: an
eighteen month study of sixty patients. Arch Dermatol
1973;107:363-8.
Roe LD, Wilson JW. Hydroxyurea therapy. Arch Dermatol
1973;108:426-7.
Rosten M. Hydroxyurea: a new antimetabolite in the
treatment of psoriasis. Br J Dermatol 1971;85:177-81.
Ellis CN, Hermann RC, Gorsulowsky DC, et al. Etretinate
therapy reduces inpatient treatment of psoriasis. J AM ACAD
DERMATOL 1987;17:787-91.
Ellis CN, Swanson NA, Grekin RC, et al. Etretinate therapy
causes increases in lipid levels in patients with psoriasis.
Arch Dermatol 1982;118:559-62.
Ellis CN, Voorhees JJ. Etretinate therapy. J AM ACAD
DERMATOL 1987;16:267-91.
Goldfarb MT, Ellis CN, Gupta AK, et al. Acitretin improves
psoriasis in a dose-dependent fashion. J AM ACAD DERMATOL
1988;18:655-62.
Goldfarb MT, Ellis CN, Voorhees JJ. Short-term and
long-term considerations in the management of psoriasis with
retinoids. Dermatologica 1987;175:100-6.
Kaplan RP, Russell DH, Lowe NJ. Etretinate therapy for
psoriasis: clinical responses, remission times, epidermal
DNA and polyamine responses. J AM ACAD DERMATOL
1983;8:95-102.
Lowe NJ, Lazarus V, Matt L. Systemic retinoid therapy for
psoriasis. J AM ACAD DERMATOL 1988;19:186-91.
Roenigk HH, Gibstine C, Glazer S, et al. Serial liver
biopsies in psoriatic patients receiving long-term
etretinate. Br J Dermatol 1985;112:77-81.
Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A
syndrome: a paradigm of retinoid side effects. J AM ACAD
DERMATOL 1987;16:1027-39.
White SI, Marks JM, Shuster S. Etretinate in pustular
psoriasis of palms and soles. Br J Dermatol 1985;113:581-5.
Wolska H, Jablonska S, Bounameaux Y. Etretinate in severe
psoriasis. J AM ACAD DERMATOL 1983;9:883-9.
Fergusson AG, Dwar WA. Observations on steroid therapy in
psoriasis. Br J Dermatol 1957;69:57-60.
Goodwin P. The effect of corticosteroids on cell turnover
in the psoriatic patient: a review. Br J Dermatol
1976;94:95-100.
Mikhail GR, Livingood CS, Mellinger RC, et al. Effect of
long-acting parental corticosteroids on adrenal function.
Arch Dermatol 1969;100:263-8.
Storrs FJ. Use and abuse of systemic corticosteroid
therapy. J AM ACAD DERMATOL 1979;1:95-105.
Adrian RM, Parrish JA, Momtaz TK, et al. Outpatient
phototherapy for psoriasis. Arch Dermatol 1981;117:623-6.
Diffey BL, Farr PM. An appraisal of ultraviolet lamps used
for the phototherapy of psoriasis. Br J Dermatol
1987;117:49-56.
Levine MJ, Parrish JA. Outpatient phototherapy of
psoriasis. Arch Dermatol 1980;116:552-4.
Parrish JA. Photobiologic principles of phototherapy and
photochemotherapy of psoriasis. Pharmacol Ther
1981;15:439-46.
Parrish JA. Ultraviolet phototherapy of psoriasis.
Pharmacol Ther 1981;15:313-20.
Stern RS, Armstrong RB, Anderson TF, et al. Effect of
continued ultraviolet B phototherapy on the duration of
remission of psoriasis: a randomized study. J AM ACAD
DERMATOL 1986;15:546-52.
Farber EM, Abel EA, Cox AJ. Long-term risks of psoralen
and UV-A therapy for psoriasis. Arch Dermatol
1983;119:426-31.
Lowe NJ, Weingarten D, Bourget T, et al. PUVA therapy for
psoriasis: comparison of oral and bath-water delivery of
8-methoxypsoralen. J AM ACAD DERMATOL 1986;14:754-60.
McEvoy MT, Stern RS. Psoralens and related compounds in
the treatment of psoriasis. Pharmacol Ther 1987;34:75-97.
Melski J, Tanenbaum, L, Parrish JA, et al. Oral
methoxsalen photochemotherapy for treatment of psoriasis: a
cooperative clinical trial. J Invest Dermatol
1977;68:328-35.
Morison WL. PUVA combination therapy. Photodermatology
1985;2:229-36.
Parrish JA, Fitzpatrick TB, Tanenbaum L, et al.
Photochemotherapy of psoriasis with oral methoxsalen and
long-wave ultraviolet light. N Engl J Med 1974;291:1207-11.
Parrish JA, LeVine MJ, Fitzpatrick TB. Oral methoxsalen
photochemotherapy of psoriasis and mycosis fungoides. Int J
Dermatol 1980;19:379-86.
Stern RS, Thibodeau LA, Kleinerman RA, et al. Risk of
cutaneous carcinoma in patients treated with oral
methoxsalen photochemotherapy for psoriasis. N Engl J Med
1979;300:809-13.
Bohm ML, Voorhees JJ. The role of the ambulatory psoriasis
treatment center as a cost-effective program for severe
psoriasis. J AM ACAD DERMATOL 1985;12:740-7.
Bohm ML, Voorhees JJ. White paper on hospitalization for
psoriasis care. J AM ACAD DERMATOL 1984;10:842-51.
Menter A, Cram DL. The Goeckerman regimen in two psoriasis
day care centers. J AM ACAD DERMATOL 1983;9:59-65.
Menter MA, Whiting DA, McWilliams J. Resistant childhood
psoriasis: an analysis of patients seen in a day car center.
Pediatr Dermatol 1984;2:8-12.
Muller SA, Perry HO. The Goeckerman treatment in
psoriasis: six decades of experience at the Mayo Clinic.
Cutis 1984;34:265-8, 270.
Perry HO, Soderstrom CW, Schulze TW. The Goeckerman
treatment of psoriasis. Arch Dermatol 1968;98:178-82.
Pittelkow MR, Perry HO, Muller SA, et al. Skin cancer in
patients with psoriasis treated with coal tar: a 25-year
follow-up study. Arch Dermatol 1981;117:465-8.
Fritsch P, Honigsmann H, Jaschke E, et al. Augmentation of
oral methoxsalen-photochemotherapy with an oral retinoic
acid derivative. J Invest Dermatol 1978;70-178-82.
Michaelsson G, Noren P, Vahlquist A. Combined therapy with
oral retinoid and PUVA baths in severe psoriasis. Br J
Dermatol 1978;99:221-2.
Van de Kerkhof PCM, Volden G, Gollnick H. Comparisons and
combinations. In: Mier P, Van de Kerkhof PCM, eds. Textbook
of psoriasis. New York: Churchill-Livingstone, 1986:268-77
Stern RS. Utilization of outpatient care for psoriasis. J
Am Acad Dermatol. 1996;35:543-545.
Nanda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an
epidemiologic survey of 112 patients. Pediatr Dermatol.
1990;7:19-21.
Leung DY, Travers JB, Giorno R, et al. Evidence for a
streptococcal superantigen-driven process in acute guttate
psoriasis. J Clin Invest. 1995;96:2106-2112.
Ryan TJ, Baker H. The prognosis of generalized pustular
psoriasis. Br J Dermatol. 1971;85:407-411.
Ohkawara A, Yasuda H, Kobayashi H, et al. Generalized
pustular psoriasis in Japan: two distinct groups formed by
differences in symptoms and genetic background. Acta Derm
Venereol. 1996;76:68-71.
Boyd AS, Menter A. Erythrodermic psoriasis. Precipitating
factors, course, and prognosis in 50 patients. J Am Acad
Dermatol. 1989;21:985-991.
Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical
therapy and phototherapy. J Am Acad Dermatol.
2001;45:487-498.
Honigsmann H. Phototherapy for psoriasis. Clin Exp
Dermatol. 2001;26:343-350.
arrish JA, Jaenicke KF. Action spectrum for phototherapy
of psoriasis. J Invest Dermatol. 1981;76:359-362.
Shelk J, Morgan P. Narrow-band UVB: a practical approach.
Dermatol Nurs. 2000;12:407-411.
Spann CT, Barbagallo J, Weinberg JM. A review of the
308-nm excimer laser in the treatment of psoriasis. Cutis.
2001;68:351-352.
Finlay AY, Khan GK. Dermatology Life Quality Index
(DLQI)--a simple practical measure for routine clinical use.
Clin Exp Dermatol. 1994;19:210-216.
Krueger GG, Feldman SR, Camisa C, et al. Two
considerations for patients with psoriasis and their
clinicians: what defines mild, moderate, and severe
psoriasis? What constitutes a clinically significant
improvement when treating psoriasis? J Am Acad Dermatol.
2000;43:281-285.
Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA.
Photochemotherapy of psoriasis with oral methoxsalen and
longwave ultraviolet light. N Engl J Med.
1974;291:1207-1211.
Helm TN, Camisa C. "Psoralens and photochemotherapy
(PUVA)". In: Handbook of Psoriasis, ed.2, Camisa C (ed),
2004, Blackwell, Oxford, UK, pp.191-214.
Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic
therapies. J Am Acad Dermatol. 2001;45:649-661.
Roenigk HH Jr, Bergfeld WF, Curtis GH. Methotrexate for
psoriasis in weekly oral doses. Arch Dermatol.
1969;99:86-93.
Heydendael VM, Spuls PI, Opmeer BC, et al. Methotrexate
versus cyclosporine in moderate-to-severe chronic plaque
psoriasis. N Engl J Med. 2003; 349:658-665.
Roenigk HH Jr, Auerbach R, Maibach H, Weinstein G, Lebwohl
M. Methotrexate in psoriasis: consensus conference. J Am
Acad Dermatol. 1998;38:478-485.
Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden
K, et al. Cyclosporine consensus conference: with emphasis
on the treatment of psoriasis. J Am Acad Dermatol.
1998;39:464-475.
van De Kerkhof PC. New developments in the treatment of
psoriasis. Skin Pharmacol Appl Skin Physiol.
2001;14:129-135.
Kumar B, Saraswat A, Kaur I. Rediscovering hydroxyurea:
its role in recalcitrant psoriasis. Int J Dermatol.
2001;40:530-534.
Duvivier A, Munro DD, Verbov J. Treatment of psoriasis
with azathioprine. Br Med J. 1974;1:49-51.
Silvis NG, Levine N. Pulse dosing of thioguanine in
recalcitrant psoriasis. Arch Dermatol. 1999;135:433-437.
Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic
acid for psoriasis. A review of pharmacology, long-term
efficacy, and safety. J Am Acad Dermatol. 1987;17:962-971.
Ameen M, Smith HR, Barker JN. Combined mycophenolate
mofetil and cyclosporine therapy for severe recalcitrant
psoriasis. Clin Exp Dermatol. 2001;26:480-483.
Gupta AK, Ellis CN, Seigel MT, et al. Sulfasalazine
improves psoriasis. A double-blind analysis. Arch Dermatol.
1990;126:487-493.
Combe B, Gouipille P, Kuntz JL, et al. Sulfasalazine in
psoriaitic arthritis: a randomized, multi-centre,
placebo-controlled study. Br J Rheumatol. 1996;35:664-668.
European FK 506 Multi-centre psoriasis study group.
Systemic tacrolimus (FK-506) is effective for the treatment
of psoriasis in a double-blind, placebo-controlled study.
Arch Dermatol. 1996;132:419-423.
Rappersberger K, Komar M, Ebelin ME, et al. Pimecrolimus
identifies a common genomic anti-inflammatory profile, is
clinically highly effective in psoriasis and is well
tolerated. J Invest Dermatol. 119;876-887, 2002.
Granstein RD. New treatments for psoriasis. N Engl J Med.
2001;345:284-287.
Ellis CN, Krueger GG. Alefacept Clinical Study Group.
Treatment of chronic plaque psoriasis by selective targeting
of memory effector T lymphocytes. N Engl J Med.
2001;345:248-255.
Lebwohl M, Tyring SK, Hamilton TK, et al. A novel targeted
T-cell modulator, efalizumab, for plaque psoriasis. N Engl J
Med. 2003;349:2004-2013.
Leonardi C, Powers JL, Matheson RT, et al. Etanercept as
monotherapy in patients with psoriasis. N Engl J Med.
2003;349:2014-2022.
Gottlieb AB, Evans R, Li S, et al. Infliximab induction
therapy for patients with severe plaque-type psoriasis: a
randomized, double-blind, placebo-controlled trial. J Am
Acad Dermatol. 2004;51:534-42.
Scher RK, Stiller M, Zhu YI. Tazarotene 0.1% gel in the
treatment of fingernail psoriasis: a double-blind,
randomized, vehicle-controlled study. Cutis.
2001;68:355-358. [top of page]
3. Acne bibliography and references
Fulton JE Jr, Plewig G, Kligman AM. Effect of chocolate on
acne vulgaris. JAMA 1969;210:2071–74
Anderson PC. Foods as the cause of acne. Am Family Phys
1971;3:102–3.
Gaby A. Commentary. Nutr Healing Feb 1997;1,10,11.
Hillstrom L et al. Comparison of oral treatment with zinc
sulfate and placebo in acne vulgaris. Br J Dermatol
1977;97:679–84.
Michaelsson G et al. A double blind study of the effect of
zinc and oxytetracycline in acne vulgaris. Br J Dermatol
1977;97:561–66.
Kligman AM et al. Oral vitamin A in acne vulgaris. Int J
Dermatol 1981;20:278–85.
Snider B, Dietman DF. Pyridoxine therapy for premenstrual
acne flare. Arch Dermatol 1974;110:130–31.
Leung LH. Pantothenic acid deficiency as the pathogenesis of
acne vulgaris. Med Hypoth 1995;44:490–92.
Shality AR, Smith JR, Parish LC, et al. Topical nicotinamide
compared with clindamycin gel in the treatment of
inflammatory acne vulgaris. Internat Dermatol
1995;34:434–37.
Bassett IB, Pannowitz DL, Barnetson RS. A comparative study
of tea-tree oil versus benzoyl peroxide in the treatment of
acne. Med J Austral 1990;53:455–58.
Hoffman D. The Herbal Handbook: A User’s Guide to Medical
Herbalism. Rochester, VT: Healing Arts Press, 1988, 23–24.
Amann W. Improvement of acne vulgaris with Agnus castus
(Agnolyt ™). Ther Gegenw. 1967;106:124–26 [in German].
Birnkrant MJ, Papadopoulos AJ, Schwartz RA, Lambert WC:
Pyoderma gangrenosum, acne conglobata, and IgA gammopathy.
Int J Dermatol 2003 Mar; 42(3): 213-6[Medline].
Champion RH, Burton JL, Burns DA, Breathnach SM, eds:
Rook/Wilkinson/Ebling Textbook of Dermatology. 6th ed.
Oxford: Blackwell Science; 1998:1967,1979.
Cunliffe WJ: Acne. 3rd ed. Martin Dunitz Publishers; 1993.
Ehrenfeld M, Samra Y, Kaplinsky N: Acne conglobata and
arthritis: report of a case and review of the literature.
Clin Rheumatol 1986 Sep; 5(3): 407-9[Medline].
el-Shahawy MA, Gadallah MF, Massry SG: Acne: a potential
side effect of cyclosporine A therapy. Nephron 1996; 72(4):
679-82[Medline].
Ena P, Zanetti S, Sechi LA: Mycobacterium chelonae I
infection mimicking acne conglobata in an immunocompetent
host. Clin Exp Dermatol 2004 Jul; 29(4): 423-5[Medline].
Jansen T, Burgdorf WH, Plewig G: Pathogenesis and treatment
of acne in childhood. Pediatr Dermatol 1997 Jan-Feb; 14(1):
17-21[Medline].
Jeong S, Lee CW: Acne conglobata: treatment with
isotretinoin, colchicine, and cyclosporin as compared with
surgical intervention. Clin Exp Dermatol 1996 Nov; 21(6):
462-3[Medline].
Leybishkis B, Fasseas P, Ryan KF, Roy R: Hidradenitis
suppurativa and acne conglobata associated with
spondyloarthropathy. Am J Med Sci 2001 Mar; 321(3):
195-7[Medline].
Leyden JJ, Mills OH, Kligman AM: Cryoprobe treatment of acne
conglobata. Br J Dermatol 1974 Mar; 90(3): 335-41[Medline].
Patterson WM, Stibich AS, Dobke M, Schwartz RA: Mutilating
facial acne conglobata. Cutis 2000 Aug; 66(2):
139-40[Medline].
Perez-Villa F, Campistol JM, Ferrando J, Botey A: Renal
amyloidosis secondary to acne conglobata. Int J Dermatol
1989 Mar; 28(2): 132-3[Medline].
Plewig G, Kligman AM: Acne and Rosacea . Berlin:
Springer-Verlag; 1993:351-5.
Roldan JC, Terheyden H, Dunsche A, et al: Acne with chronic
recurrent multifocal osteomyelitis involving the mandible as
part of the SAPHO syndrome: case report. Br J Oral
Maxillofac Surg 2001 Apr; 39(2): 141-4[Medline].
Schackert K, Scholz S, Steinbauer-Rosenthal I, et al:
Letter: HL-A antigens in acne conglobata: a negative study.
Arch Dermatol 1974 Sep; 110(3): 468[Medline].
Shimomura Y, Nomoto S, Yamada S, et al: Chronic
glomerulonephritis remarkably improved after surgery for
acne conglobata of the buttocks. Br J Dermatol 2001 Aug;
145(2): 363-4[Medline].
Tan BB, Lear JT, Smith AG: Acne fulminans and erythema
nodosum during isotretinoin therapy responding to dapsone.
Clin Exp Dermatol 1997 Jan; 22(1): 26-7[Medline].
Vasey FB, Fenske NA, Clement GB, et al: Immunological
studies of the arthritis of acne conglobata and hidradenitis
suppurativa. Clin Exp Rheumatol 1984 Oct-Dec; 2(4):
309-11[Medline].
Velez A, Alcala J, Fernandez-Roldan JC: Pyoderma gangrenosum
associated with acne conglobata. Clin Exp Dermatol 1995 Nov;
20(6): 496-8[Medline].
Weinrauch L, Peled I, Hacham-Zadeh S, Wexler MR: Surgical
treatment of severe acne conglobata. J Dermatol Surg Oncol
1981 Jun; 7(6): 492-4[Medline].
Wollenberg A, Wolff H, Jansen T, et al: Acne conglobata and
Klinefelter's syndrome. Br J Dermatol 1997 Mar; 136(3):
421-3[Medline].
Yeon HB, Lindor NM, Seidman JG, Seidman CE: Pyogenic
arthritis, pyoderma gangrenosum, and acne syndrome maps to
chromosome 15q. Am J Hum Genet 2000 Apr; 66(4):
1443-8[Medline].
Zaba R: Pathogenesis and treatment of acne vulgaris. Postepy
Dermatol Alergol (Postepy) 2001; 18: 131-140.
Ziff M, Maliakkal J: Acne conglobata and arthritis. Ann
Intern Med 1983 Mar; 98(3): 417[Medline].
[top of page] |
